{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:37:22Z","timestamp":1792780642844,"version":"4.5.0"},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Gene-expression biomarkers for diffuse large B-cell lymphoma (DLBCL) are often transported across retrospective cohorts that differ in treatment, assay platform, and clinical annotation. Using REMARK as the reporting framework, we audited prognostic associations with fixed scoring rules. Four Gene Expression Omnibus cohorts were harmonized for survival analysis. Treatment context was assessed after outcome-blind transcriptional state discovery. A directly mapped five-gene historical benchmark was evaluated with continuous Cox models in four R-CHOP cohorts. A 76-gene program selected in GSE31312 and GSE10846 served as a case study of two-cohort discovery, with GSE87371 as the only full-coverage independent evaluation and GSE32918 as a cross-platform sensitivity analysis. Coverage ablation, technical replicates, matched random programs, meta-analysis, and clinical-increment analyses assessed attenuation. The survival analyses included 470, 232, 87, and 140 patients. State composition was strongly associated with CHOP versus R-CHOP context in GSE10846 (Cramer\u2019s V\u2009=\u20090.986). The historical score\u2019s unadjusted random-effects hazard ratio (HR) was 1.35 (95% confidence interval 1.04\u20131.75); the prediction interval crossed the null (0.77\u20132.37). Common age\/sex adjustment yielded HR 1.27 (1.05\u20131.54), with a prediction interval of 0.94\u20131.72. The 76-gene program was not independently validated in GSE87371 (unadjusted HR 1.23, 0.87\u20131.75; IPI\/COO-adjusted HR 0.88, 0.56\u20131.40; age\/sex-adjusted HR 1.09, 0.76\u20131.55). Its effect exceeded most matched random programs, but cross-cohort attenuation was pronounced and estimated clinical increment was negligible. With only 32 validation events, modest effects remain compatible with the data. Public DLBCL transcriptomic associations can be cohort-specific despite fixed scoring rules. Independent full-coverage evaluation and transparent treatment and platform audits should precede claims of general prognostic utility.<\/jats:p>","DOI":"10.1371\/journal.pone.0360937","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:39:08Z","timestamp":1792777148000},"page":"e0360937","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A public-data audit of transcriptomic prognostic transportability in R-CHOP-treated diffuse large B-cell lymphoma"],"prefix":"10.1371","volume":"21","author":[{"given":"Yongqing","family":"Li","sequence":"first","affiliation":[{"name":"Jieyang People\u2019s Hospital","place":["Jieyang, Guangdong, China"],"department":["Department of Hematology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Xiong","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Sun Yat-sen University","place":["Guangzhou, Guangdong, China"],"department":["Department of Laboratory Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Feng","sequence":"additional","affiliation":[{"name":"Baiyun Hospital of The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"],"department":["Pathology and Laboratory Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Jieyang People\u2019s Hospital","place":["Jieyang, Guangdong, China"],"department":["Department of Laboratory Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Qin","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"],"department":["Department of Gastroenterology"]},{"name":"Jiexi County Second People\u2019s Hospital","place":["Jieyang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyun","family":"Hong","sequence":"additional","affiliation":[{"name":"Macau University of Science and Technology","place":["Macau SAR, China"],"department":["Faculty of Medicine, School of Pharmacy, Medical Science Division"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8291-7545","authenticated-orcid":true,"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Rongcheng District Central Hospital","place":["Jieyang, Guangdong, China"],"department":["Department of Laboratory Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"4","key":"pone.0360937.ref001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"B Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"6769","key":"pone.0360937.ref002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"AA Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"15","key":"pone.0360937.ref003","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"R Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"22","key":"pone.0360937.ref004","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"G Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"18","key":"pone.0360937.ref005","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"IS Lossos","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0360937.ref006","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"R Malumbres","year":"2008","journal-title":"Blood"},{"issue":"16","key":"pone.0360937.ref007","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"LM McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"pone.0360937.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration","volume":"9","author":"DG Altman","year":"2012","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0360937.ref009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"R Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"pone.0360937.ref010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"26","author":"C Visco","year":"2012","journal-title":"Leukemia"},{"issue":"14","key":"pone.0360937.ref011","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0360937.ref012","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/1078-0432.CCR-16-1922","article-title":"Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P-mutated diffuse large B-cell lymphoma: analysis of 361 cases","volume":"23","author":"S Dubois","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"pone.0360937.ref013","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.12045","article-title":"Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome","volume":"159","author":"SL Barrans","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"pone.0360937.ref014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model","volume":"39","author":"DA Schoenfeld","year":"1983","journal-title":"Biometrics"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:39:12Z","timestamp":1792777152000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360937"}},"subtitle":[],"editor":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[{"name":"Duke University Medical Center: Duke University Hospital","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0360937","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]}}}